Name: Retatrutide
Brand: Vial Labs
SKU: RT10
Price: 111.99 EUR
Availability: InStock

Question 1

What is retatrutide?

Accepted Answer

A synthetic peptide that activates three receptors at once — GIP, GLP-1 and glucagon — developed under the code LY3437943.

Question 2

Why include glucagon receptor activity?

Accepted Answer

Glucagon opposes insulin, but its receptor also drives energy expenditure and hepatic substrate handling. Whether the combination outperforms the parts is the question the compound was built to answer.

Question 3

How does it differ from tirzepatide?

Accepted Answer

Tirzepatide covers two receptors, GIP and GLP-1. Retatrutide adds the third, glucagon.

Question 4

Is it an approved medicine?

Accepted Answer

No. It is investigational and has not been approved by any medicines regulator. This vial is laboratory research material and is not for human or veterinary use.

Question 5

What stage is the research at?

Accepted Answer

It completed phase 2 and entered the phase 3 TRIUMPH programme. Published data are dose-dependent and promising, but the full safety picture is not yet established.

Question 6

What documentation comes with it?

Accepted Answer

A batch certificate of analysis with HPLC purity, linked on this page and verifiable on the testing laboratory's site.